Clinical Trial Update: Combination of Decitabine and Midostaurin in Patients Older Than 60 With Newly Diagnosed or Relapsed Refractory Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the combination of decitabine and midostaurin in patients over 60 with newly diagnosed or relapsed/refractory acute myeloid leukemia; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Dacogen (decitabine)
• Rydapt (midostaurin)

Snippet

Sponsor: University of Kansas | Conditions: Acute Myeloid Leukemia | Phase 1 | Status: COMPLETED